Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazunori Kanehira
Breast Carcinoma With Amplified HER2: A Gene Expression Signature Specific for Trastuzumab Resistance and Poor Prognosis
Modern Pathology
Forensic Medicine
Pathology
Treatment Recommendations to Cancer Patients in the Context of FDA Guidance for Next Generation Sequencing
BMC Medical Informatics and Decision Making
Health Policy
Health Informatics
Related publications
Src, a Potential Target for Overcoming Trastuzumab Resistance in HER2-positive Breast Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma
Clinical Breast Cancer
Cancer Research
Oncology
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
Clinical Medicine Insights: Oncology
Oncology
Cytokeratin 5/6 Fingerprinting in HER2-positive Tumors Identifies a Poor Prognosis and Trastuzumab-Resistant Basal-Her2 Subtype of Breast Cancer
Oncotarget
Oncology
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers With Poor Prognosis
Cancer Research
Cancer Research
Oncology
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Gene Expression Profiling of Carcinoma Breast and Its, Prognostic Signature: A Review
Academia Journal of Surgery
Flotillin2 Expression Correlates With HER2 Levels and Poor Prognosis in Gastric Cancer
PLoS ONE
Multidisciplinary